Future work is needed to determine the full utility of GCNT1 as a screening tool in predicting which tumors are favored to remain indolent versus metastasize as well as mechanisms as to how GCNT1 and its product contribute to PCa progression. Here, GCNT1 is linked to posterior cortical atrophy.